Eli Lilly and Co (LLY)
770.00
-17.02
(-2.16%)
USD |
NYSE |
May 16, 16:00
771.72
+1.72
(+0.22%)
After-Hours: 16:26
Eli Lilly Debt to Equity Ratio: 2.046 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2024 | 2.046 |
December 31, 2023 | 2.342 |
September 30, 2023 | 1.798 |
June 30, 2023 | 1.701 |
March 31, 2023 | 1.688 |
December 31, 2022 | 1.525 |
September 30, 2022 | 1.578 |
June 30, 2022 | 1.968 |
March 31, 2022 | 1.769 |
December 31, 2021 | 1.880 |
September 30, 2021 | 2.203 |
June 30, 2021 | 2.563 |
March 31, 2021 | 2.349 |
December 31, 2020 | 2.942 |
September 30, 2020 | 3.506 |
June 30, 2020 | 3.989 |
March 31, 2020 | 5.596 |
December 31, 2019 | 5.876 |
September 30, 2019 | 4.501 |
June 30, 2019 | 5.678 |
March 31, 2019 | 6.437 |
December 31, 2018 | 1.048 |
September 30, 2018 | 0.9694 |
June 30, 2018 | 1.058 |
March 31, 2018 | 0.8052 |
Date | Value |
---|---|
December 31, 2017 | 1.177 |
September 30, 2017 | 0.9043 |
June 30, 2017 | 0.8731 |
March 31, 2017 | 0.7303 |
December 31, 2016 | 0.7357 |
September 30, 2016 | 0.5997 |
June 30, 2016 | 0.6375 |
March 31, 2016 | 0.5414 |
December 31, 2015 | 0.5475 |
September 30, 2015 | 0.5308 |
June 30, 2015 | 0.5453 |
March 31, 2015 | 0.551 |
December 31, 2014 | 0.5218 |
September 30, 2014 | 0.3173 |
June 30, 2014 | 0.2953 |
March 31, 2014 | 0.2871 |
December 31, 2013 | 0.2957 |
September 30, 2013 | 0.3128 |
June 30, 2013 | 0.349 |
March 31, 2013 | 0.3652 |
December 31, 2012 | 0.3746 |
September 30, 2012 | 0.3436 |
June 30, 2012 | 0.385 |
March 31, 2012 | 0.365 |
December 31, 2011 | 0.516 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
1.525
Minimum
Dec 2022
5.876
Maximum
Dec 2019
2.875
Average
2.272
Median
Debt to Equity Ratio Benchmarks
Amgen Inc | 12.75 |
Biogen Inc | 0.4299 |
Johnson & Johnson | 0.4803 |
Vertex Pharmaceuticals Inc | 0.00 |
Viking Therapeutics Inc | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 63.94B |
Total Liabilities (Quarterly) | 51.05B |
Shareholders Equity (Quarterly) | 12.81B |
Current Ratio | 1.354 |
Net Debt Paydown Yield | -0.27% |